The treatment of Allergies & Cancer Risk Reduction with vitamins

Allergies and Cancer Risk Reduction: Mitamins custom make quality formulas for the treatment of Allergies & Cancer Risk Reduction with vitamins. A Allergies & Cancer Risk Reduction formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Allergies and Cancer Risk Reduction

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Lactobacillus acidolphilus
    100
    mg
    *
    CoQ-10
    15
    mg
    *
    MSM
    100
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Grape Seed Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Green Tea Extract
    50
    mg
    *
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    Betaine HCl
    50
    mg
    *
    Thymus
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Allergies and Cancer Risk Reduction
Serving Size:4-5

Allergies and Cancer Risk Reduction Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
AZOR(TM) Receives FDA Approval For Treatment Of High Blood Pressure
Daiichi Sankyo, Inc. announced that the United States Food and Drug Administration (FDA) has approved AZOR(TM) (amlodipine and olmesartan medoxomil) for the treatment of hypertension, also known as high blood pressure.
Vocational Services Less Effective Than Individual Placement And Support Programs At Getting Mentally Ill Into Competitive Employment
People with severe mental illness receive twice the benefit from an IPS (Individual Placement Support) program at establishing themselves in competitive employment, when compared to vocational services*, according to an article in The Lancet, this week's issue. IPS involves job searching based on the patient's preference. It provides the patient and employer with continuing support from an employment specialist who works for the local mental health service.
This information concerning the support of Allergies and Cancer Risk Reduction treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments